Abridge
Abridge is a privately held healthcare AI company that builds ambient-AI clinical documentation and conversation-summarization tools used by physicians, nurses, and health systems. The platform listens to patient-clinician encounters and automatically generates structured clinical notes, billing codes, and patient summaries. In June 2026, Abridge announced parallel strategic partnerships with Nvidia (for compute infrastructure) and Eli Lilly (to deploy its platform in Lilly-sponsored clinical trial recruitment and consent workflows).
Company Info
Funding & Investor Relations
Notable Investors
- Lightspeed Venture Partners
- Bessemer Venture Partners
- Spark Capital
- Union Square Ventures
- Khosla Ventures
- NVIDIA
- Eli Lilly and Company (strategic investment, June 2026)
IPO Outlook / Plans
Not publicly disclosed; private AI-health company with significant strategic investor base.
Upcoming Milestones & Key Dates
First deployments of Abridge Clinical Trial Suite in Lilly-sponsored trials
Continued Nvidia compute-infrastructure integration for model training and inference
Clinical Development Pipeline
Abridge Ambient Clinical Documentation Platform
Target: Conversational AI summarization of patient-clinician encountersAbridge Clinical Trial Suite
Target: Ambient-AI platform adapted for clinical trial workflows (Lilly partnership, June 2026)Abridge Enterprise Integration
Target: EHR-native ambient AI for documentation, coding, and patient summariesRecent News
No recent news updates available for this company.
Leadership Team
Dr. Shiv Rao
Co-Founder and Chief Executive Officer
Dr. Zachary Lipton
Co-Founder and Chief Technology Officer
Careers & Job Openings